Filgrastim Completed Phase 2 Trials for chronic Chronic myelogenous leukemia / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01390402Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG